Nuclear Pharma Danmark ApS: Financial statements 2018
CVR: 37815578
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
Nuclear Pharma Danmark ApS (CVR 37815578) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -6,000 and a net result of DKK -5,271 compared with DKK -21,200 the year before. Equity in the 2018 report amounted to DKK 25,075. The solvency ratio was 73.8%.
- Gross Profit
- DKK -6,000
- Profit/Loss
- DKK -5,271
- Equity
- DKK 25,075
- Total Assets
- DKK 33,997
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -6 t. | -5 t. | 25 t. | - |
| 2017 | - | -21 t. | -21 t. | 30 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Nuclear Pharma Danmark ApS
Nuclear Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in Odder, founded in 2016. The company has been dissolved on 29 July 2019. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. In 2018, the company reported a gross profit of DKK -6,000 and a net result of DKK -5,271 compared with DKK -21,200 the year before. Equity in the 2018 report amounted to DKK 25,075.